Pharma News

Gilead has made progress in its effort to reposition failed Ebola drug remdesivir as a treatment for the coronavirus sweeping across China.

Today the U.

Bayer on Friday won an endorsement from the European Union’s drug regulator for its prostate cancer drug darolutamide, putting it on track for approval, as it takes on rival products by Pfizer and J...

FINDINGSA study by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that using an immunotherapy drug called NKTR-214, also known as bempegaldesleukin, in combination with an infusi...

Takeda, which has been cutting costs after closing its $60 billion deal for Shire last year, is putting a Shire plant up for sale.

The World Health Organization announced Thursday that the outbreak of a deadly and fast-spreading strain of coronavirus constitutes a global health emergency.

Exscientia and and Japanese company Sumitomo Dainippon have announced that a joint AI-developed drug has been initiated for the treatment of obsessive-compulsive disorder as an initial indication.

As many readers will already know, atherosclerotic plaque-deposits on the inner walls of arteries are a frequent cause of heart attacks and strokes.

(Reuters) - Acceleron Pharma Inc (XLRN.

SHANGHAI, China, January 29, 2020–WuXi Biologics (“WuXi Bio”) (2269.

The FDA has found a handful of issues with Biocon’s small molecule API facility in Bengaluru, India.

(HealthDay)—For patients with unresectable hepatocellular carcinoma, the combination of atezolizumab and bevacizumab is associated with longer time to deterioration of patient-reported quali...